Showing results (211-220 of 232) with videos related to
Sort By:
Pageof 24
Metabolism: Clinical and Experimental|November 4, 2019
Downregulation of PHGDH expression and hepatic serine level contribute to the development of fatty liver diseaseWoo-Cheol Sim, Wonseok Lee, Hyungtai Sim, et al.Journal of the American Academy of Dermatology|September 6, 2022
First-line pembrolizumab versus dabrafenib/trametinib treatment for BRAF V600-mutant advanced melanomaChang Gon Kim, Miso Kim, Jieon Hwang, et al.Chemosphere|September 14, 2019
Neurochemical and behavioral analysis by acute exposure to bisphenol A in zebrafish larvae modelSeong Soon Kim, Kyu-Seok Hwang, Jung Yoon Yang, et al.Molecules (Basel, Switzerland)|May 25, 2019
Functional Fragments of AIMP1-Derived Peptide (AdP) and Optimized Hydrosol for Their Topical Deposition by Box-Behnken DesignJeong-Jun Lee, Young-Min Han, Tae-Wan Kwon, et al.Pharmaceutics|September 29, 2020
Quasi-Irreversible Inhibition of CYP2D6 by BerberineHa Gyeong Kim, Han Sol Lee, Jang Su Jeon, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2024
Clinical Activity of TGF-β Inhibitor Vactosertib in Combination with Imatinib in Desmoid Tumors: A Multicenter Phase Ib/II StudyJin-Hee Ahn, Jeeyun Lee, Changhee Park, et al.Biomaterials|May 22, 2022
Development of human pluripotent stem cell-derived hepatic organoids as an alternative model for drug safety assessmentHyemin Kim, Ilkyun Im, Jang Su Jeon, et al.Scientific Reports|September 13, 2024
Differential genotoxicity of Polygoni Multiflori in rat and human: insights from Ames test and S9 metabolic activation systemSu-Min Bak, Seng-Min Back, Da Yeon Kim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2026
Phase IB/II Trial with Correlative Analyses of Doxorubicin plus Durvalumab Combination in Patients with Advanced Soft Tissue SarcomaKum-Hee Yun, Nam Suk Sim, Su-Jin Shin, et al.Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|January 23, 2019
Physciosporin suppresses the proliferation, motility and tumourigenesis of colorectal cancer cellsİsa Taş, Jin Han, So-Yeon Park, et al.Pageof 24